There has been an important change in the clinical characteristics and immune profile of
Coronavirus disease 2019 (COVID‐19) patients during the pandemic thanks to the …

Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

Messenger RNA (mRNA) vaccines against COVID‐19 are the first authorized biological
preparations developed using this platform. During the pandemic, their administration has …

Since its first emergence in late 2019, severe acute respiratory syndrome coronavirus-2 has
claimed more than 6.5 million lives worldwide and continues to infect hundreds of thousands …

Vaccination against SARS-CoV-2 has become a central public health issue, primarily for
vulnerable populations such as individuals with Chronic Liver Disease (CLD). Increased …

Background Oral adverse events (AEs) following COVID-19 vaccination have been
sporadically reported during the previous months, warranting further investigation for their …

Coronavirus disease 2019 affected child health and impacted learning because of the
resulting onsite school closures. This prospective cohort study included children aged 10 …

Abstract Purpose of Review The COVID-19 vaccines have proved essential in our defense
against the COVID-19 pandemic. However, concerns regarding allergic reactions to the …

This guidance updates 2021 GRADE (Grading of Recommendations Assessment,
Development and Evaluation) recommendations regarding immediate allergic reactions …

This study aimed at producing an updated assessment of the incidence of anaphylaxis
associated with COVID-19 vaccines based on pharmacovigilance data. Anaphylactic …